VTRS
Viatris Inc
A global healthcare company that makes and sells generic medicines, complex drugs, and iconic brand-name products like Lipitor® and Lyrica®, reaching hundreds of millions of patients across more than a hundred countries. Viatris was created in 2020 when the drugmaker Mylan merged with Upjohn, the off-patent medicines arm of Pfizer, uniting two long pharmaceutical histories. It has since streamlined by selling off its women's health, over-the-counter, and active-ingredient businesses.
CUSIP: 92556V106HealthcareUS4 holders
Total Value
$1.54B
Total Shares
98.01M
Net Share Change
-2.00M
Activity
2 buying1 selling
Investor
Value
Shares
Weight
Change
